vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Leonardo DRS, Inc. (DRS). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $1.1B, roughly 1.2× Leonardo DRS, Inc.). Leonardo DRS, Inc. runs the higher net margin — 9.6% vs 0.9%, a 8.7% gap on every dollar of revenue. On growth, Leonardo DRS, Inc. posted the faster year-over-year revenue change (8.1% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 24.1%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Leonardo DRS, Inc. is a United States–based defense contractor. Originally founded as DRS Technologies, Inc. and traded on the NYSE, it was acquired by Leonardo’s predecessor Finmeccanica in 2008. Leonardo DRS provides advanced defense technologies and systems primarily to the U.S. military.

ALHC vs DRS — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.2× larger
ALHC
$1.2B
$1.1B
DRS
Growing faster (revenue YoY)
DRS
DRS
+82.8% gap
DRS
8.1%
-74.7%
ALHC
Higher net margin
DRS
DRS
8.7% more per $
DRS
9.6%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
24.1%
DRS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
DRS
DRS
Revenue
$1.2B
$1.1B
Net Profit
$11.4M
$102.0M
Gross Margin
25.4%
Operating Margin
11.9%
Net Margin
0.9%
9.6%
Revenue YoY
-74.7%
8.1%
Net Profit YoY
14.6%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
DRS
DRS
Q1 26
$1.2B
Q4 25
$1.0B
$1.1B
Q3 25
$993.7M
$960.0M
Q2 25
$1.0B
$829.0M
Q1 25
$926.9M
$799.0M
Q4 24
$701.2M
$981.0M
Q3 24
$692.4M
$812.0M
Q2 24
$681.3M
$753.0M
Net Profit
ALHC
ALHC
DRS
DRS
Q1 26
$11.4M
Q4 25
$-11.0M
$102.0M
Q3 25
$3.7M
$72.0M
Q2 25
$15.7M
$54.0M
Q1 25
$-9.1M
$50.0M
Q4 24
$-31.1M
$89.0M
Q3 24
$-26.4M
$57.0M
Q2 24
$-24.0M
$38.0M
Gross Margin
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
25.4%
Q3 25
23.1%
Q2 25
23.8%
Q1 25
22.7%
Q4 24
24.0%
Q3 24
22.0%
Q2 24
22.4%
Operating Margin
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
-1.0%
11.9%
Q3 25
0.8%
9.7%
Q2 25
2.2%
8.4%
Q1 25
-0.6%
7.4%
Q4 24
-3.2%
12.2%
Q3 24
-2.8%
9.2%
Q2 24
-2.7%
7.3%
Net Margin
ALHC
ALHC
DRS
DRS
Q1 26
0.9%
Q4 25
-1.1%
9.6%
Q3 25
0.4%
7.5%
Q2 25
1.5%
6.5%
Q1 25
-1.0%
6.3%
Q4 24
-4.4%
9.1%
Q3 24
-3.8%
7.0%
Q2 24
-3.5%
5.0%
EPS (diluted)
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
$-0.04
$0.38
Q3 25
$0.02
$0.26
Q2 25
$0.07
$0.20
Q1 25
$-0.05
$0.19
Q4 24
$-0.15
$0.34
Q3 24
$-0.14
$0.21
Q2 24
$-0.13
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
DRS
DRS
Cash + ST InvestmentsLiquidity on hand
$705.6M
$647.0M
Total DebtLower is stronger
$321.0M
Stockholders' EquityBook value
$206.9M
$2.7B
Total Assets
$1.3B
$4.5B
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
DRS
DRS
Q1 26
$705.6M
Q4 25
$604.2M
$647.0M
Q3 25
$644.1M
$309.0M
Q2 25
$503.8M
$278.0M
Q1 25
$479.5M
$380.0M
Q4 24
$470.6M
$598.0M
Q3 24
$381.0M
$198.0M
Q2 24
$363.7M
$149.0M
Total Debt
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
$323.2M
$321.0M
Q3 25
$322.7M
$326.0M
Q2 25
$322.3M
$331.0M
Q1 25
$321.9M
$335.0M
Q4 24
$321.4M
$340.0M
Q3 24
$212.0M
$345.0M
Q2 24
$211.7M
$351.0M
Stockholders' Equity
ALHC
ALHC
DRS
DRS
Q1 26
$206.9M
Q4 25
$179.3M
$2.7B
Q3 25
$161.9M
$2.6B
Q2 25
$141.0M
$2.6B
Q1 25
$108.1M
$2.6B
Q4 24
$99.9M
$2.6B
Q3 24
$114.5M
$2.5B
Q2 24
$123.7M
$2.4B
Total Assets
ALHC
ALHC
DRS
DRS
Q1 26
$1.3B
Q4 25
$1.1B
$4.5B
Q3 25
$1.1B
$4.2B
Q2 25
$1.0B
$4.1B
Q1 25
$895.6M
$4.1B
Q4 24
$782.1M
$4.2B
Q3 24
$692.3M
$3.9B
Q2 24
$716.3M
$3.8B
Debt / Equity
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
1.80×
0.12×
Q3 25
1.99×
0.12×
Q2 25
2.29×
0.13×
Q1 25
2.98×
0.13×
Q4 24
3.22×
0.13×
Q3 24
1.85×
0.14×
Q2 24
1.71×
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
DRS
DRS
Operating Cash FlowLast quarter
$128.7M
$425.0M
Free Cash FlowOCF − Capex
$376.0M
FCF MarginFCF / Revenue
35.5%
Capex IntensityCapex / Revenue
4.6%
Cash ConversionOCF / Net Profit
11.27×
4.17×
TTM Free Cash FlowTrailing 4 quarters
$227.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
DRS
DRS
Q1 26
$128.7M
Q4 25
$-50.4M
$425.0M
Q3 25
$144.6M
$107.0M
Q2 25
$29.1M
$-28.0M
Q1 25
$16.6M
$-138.0M
Q4 24
$-8.7M
$443.0M
Q3 24
$26.2M
$59.0M
Q2 24
$23.5M
$34.0M
Free Cash Flow
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
$-55.4M
$376.0M
Q3 25
$139.1M
$77.0M
Q2 25
$21.1M
$-56.0M
Q1 25
$8.4M
$-170.0M
Q4 24
$-18.0M
$414.0M
Q3 24
$16.9M
$47.0M
Q2 24
$11.8M
$0
FCF Margin
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
-5.5%
35.5%
Q3 25
14.0%
8.0%
Q2 25
2.1%
-6.8%
Q1 25
0.9%
-21.3%
Q4 24
-2.6%
42.2%
Q3 24
2.4%
5.8%
Q2 24
1.7%
0.0%
Capex Intensity
ALHC
ALHC
DRS
DRS
Q1 26
Q4 25
0.5%
4.6%
Q3 25
0.6%
3.1%
Q2 25
0.8%
3.4%
Q1 25
0.9%
4.0%
Q4 24
1.3%
3.0%
Q3 24
1.3%
1.5%
Q2 24
1.7%
4.5%
Cash Conversion
ALHC
ALHC
DRS
DRS
Q1 26
11.27×
Q4 25
4.17×
Q3 25
38.77×
1.49×
Q2 25
1.86×
-0.52×
Q1 25
-2.76×
Q4 24
4.98×
Q3 24
1.04×
Q2 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons